Clinical Trials
29
Active:2
Completed:7
Trial Phases
3 Phases
Phase 1:12
Phase 2:12
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (42.9%)Phase 2
12 (42.9%)Phase 3
4 (14.3%)Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
Phase 1
Not yet recruiting
- Conditions
- Inoperable Locally Advanced HER2-Negative Breast CancerMetastatic HER2-Negative Breast Cancer
- Interventions
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 180
- Registration Number
- NCT06942234
Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC
Phase 1
Not yet recruiting
- Conditions
- Advanced Non-small Cell Lung Cancer
- Interventions
- Drug: Furmonertinib Mesylate
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 288
- Registration Number
- NCT06868732
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study
Phase 2
Not yet recruiting
- Conditions
- Advanced Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 220
- Registration Number
- NCT06775483
JSKN033 in Chinese Subjects with Advanced Malignant Tumors
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 430
- Registration Number
- NCT06770881
JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer
Phase 3
Not yet recruiting
- Conditions
- Ovarian CancerPrimary PeritonealFallopian Tube Cancers
- Interventions
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 430
- Registration Number
- NCT06751485
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found